life science research products, biological research products, biotechnology
Use * as wildcard:
iclines
RNAStorm
Pluripro

Rapamycin

Rapamycin
print page
Size: 50 mg
$180.00
Add to basket
Catalogue number:
10-1104-02
Name:
Rapamycin
Supplier:
Availability:

mTOR inhibitor

Data sheet:

Click to view / download

Applications:


mTOR inhibitor

Product Type:
Biochemicals & reagents
CAS Number:
53123-88-9
Alternative Names:
Sirolimus
Storage Temp:
-20°C
Molecular Weight:
914.17
Reference:
1) Kay, et al. (1991) Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 72 544 / 2) Mita, et al., (2003) The molecular target of rapamycin (mTOR) as a therapeutic target against cancer Cancer Biol. Ther. 2(4 Suppl 1), S169 / 3) Lamming, et al. ( 2012). Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335 1638 / 4) Sarkar et.al. (2009), Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies Cell Death and Differentiation 16, 46
Additional Information:
Rapamycin (53123-88-9) is a clinically useful immunosuppressant. Inhibits the response to interleukin-2 blocking activation of T- and B-cells.1 Rapamycin forms a complex with cytosolic FK-binding protein 12 (FKB12) that binds to mTOR Complex1(mTORC1) inhibiting the mammalian target of rapamycin (mTOR).2 Rapamycin also binds to mTORC2 leading to decreased glucose tolerance and insensitivity to insulin.3 Induces autophagy.4